150 related articles for article (PubMed ID: 27992961)
1. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
2. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
4. Update on the risks of benign adrenocortical incidentalomas.
Di Dalmazi G
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):193-199. PubMed ID: 28248753
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
Podbregar A; Janez A; Goricar K; Jensterle M
BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
[TBL] [Abstract][Full Text] [Related]
7. MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
Belokovskaya R; Ravikumar A; Arumugam D; Izadmehr S; Goddard GM; Geer EB; Levine AC
Endocr Pract; 2019 Aug; 25(8):846-853. PubMed ID: 31070948
[No Abstract] [Full Text] [Related]
8. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
Yener S; Baris M; Peker A; Demir O; Ozgen B; Secil M
Clin Endocrinol (Oxf); 2017 Nov; 87(5):425-432. PubMed ID: 28656620
[TBL] [Abstract][Full Text] [Related]
9. The functional status of incidentally discovered bilateral adrenal lesions.
Androulakis II; Kaltsas GA; Markou A; Tseniklidi E; Kafritsa P; Pappa T; Papanastasiou L; Piaditis GP
Clin Endocrinol (Oxf); 2011 Jul; 75(1):44-9. PubMed ID: 21521282
[TBL] [Abstract][Full Text] [Related]
10. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
de Paula MP; Moraes AB; de Souza MDGC; Cavalari EMR; Campbell RC; Fernandes GDS; Farias MLF; Mendonça LMC; Madeira M; Bouskela E; Kraemer-Aguiar LG; Vieira Neto L
J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
[TBL] [Abstract][Full Text] [Related]
11. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?
Muscogiuri G; Sorice GP; Prioletta A; Mezza T; Cipolla C; Salomone E; Giaccari A; Pontecorvi A; Della Casa S
Clin Endocrinol (Oxf); 2011 Mar; 74(3):300-5. PubMed ID: 21070314
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: The cause-effect relationship?
Marina LV; Ivović M; Tančić-Gajić M; Arizanović Z; Raković D; Milin-Lazović J; Kendereški A; Micić D; Vujović S
Clin Endocrinol (Oxf); 2018 Apr; 88(4):541-548. PubMed ID: 29288564
[TBL] [Abstract][Full Text] [Related]
13. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
Akkus G; Evran M; Sert M; Tetiker T
Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
[TBL] [Abstract][Full Text] [Related]
14. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.
Perogamvros I; Vassiliadi DA; Karapanou O; Botoula E; Tzanela M; Tsagarakis S
Eur J Endocrinol; 2015 Dec; 173(6):719-25. PubMed ID: 26330465
[TBL] [Abstract][Full Text] [Related]
16. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
Imga NN; Topcuoglu C; Berker D; Turhan T
Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
[TBL] [Abstract][Full Text] [Related]
17. Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome.
Ribeiro Cavalari EM; de Paula MP; Arruda M; Carraro N; Martins A; de Souza K; Coelho MC; de Oliveira E Silva de Morais NA; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2018 Nov; 89(5):586-595. PubMed ID: 30044007
[TBL] [Abstract][Full Text] [Related]
18. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
[TBL] [Abstract][Full Text] [Related]
19. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
Arruda M; Mello Ribeiro Cavalari E; Pessoa de Paula M; Fernandes Cordeiro de Morais F; Furtado Bilro G; Alves Coelho MC; de Oliveira E Silva de Morais NA; Choeri D; Moraes A; Vieira Neto L
J Hum Hypertens; 2017 Dec; 32(1):3-11. PubMed ID: 29176595
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma.
Eller-Vainicher C; Morelli V; Salcuni AS; Battista C; Torlontano M; Coletti F; Iorio L; Cairoli E; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
Eur J Endocrinol; 2010 Dec; 163(6):925-35. PubMed ID: 20881060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
